Double-Blind Method

ATLANTA — Results of a double-blind, randomized, placebo-controlled trial showed a clear benefit of tofacitinib in controlling disease flares in juvenile idiopathic arthritis, according to a speaker at ACR/ARP 2019.

Health care providers’ expectations for the effectiveness of a treatment may affect clinical interactions and engender a “socially transmitted placebo effect,” according to results of a study published in Nature Human Behaviour that simulated a clinical interaction.

Study participants who consumed flavanol-rich dark chocolate experienced no beneficial effects in retinal perfusion or visual function compared with those who consumed milk chocolate.

The FDA has extended approval for ixekizumab injection 80 mg/mL to treat adults with ankylosing spondylitis – or radiographic axial spondyloarthritis - according to an Eli Lilly press release.

The FDA has accepted a new drug application for IDP-123, a lotion for the treatment of acne, according to an announcement from Bausch Health and Ortho Dermatologics, Bausch’s dermatology business.

Ingenol mebutate gel 0.027% was superior to vehicle treatment for actinic keratosis on the face, scalp and chest with areas 250 cm2.